Sirtuin 1 regulation of developmental genes during differentiation of stem cells
Article 2010 en
Authors
VC
Vincenzo Calvanese
EL
Ester Lara
BS
Beatriz Suárez-Álvarez
Abstract
1 min read
The longevity-promoting NAD + –dependent class III histone deacetylase Sirtuin 1 (SIRT1) is involved in stem cell function by controlling cell fate decision and/or by regulating the p53-dependent expression of NANOG. We show that SIRT1 is down-regulated precisely during human embryonic stem cell differentiation at both mRNA and protein levels and that the decrease in Sirt1 mRNA is mediated by a molecular pathway that involves the RNA-binding protein HuR and the arginine methyltransferase coactivator-associated arginine methyltransferase 1 (CARM1). SIRT1 down-regulation leads to reactivation of key developmental genes such as the neuroretinal morphogenesis effectors DLL4, TBX3, and PAX6, which are epigenetically repressed by this histone deacetylase in pluripotent human embryonic stem cells. Our results indicate that SIRT1 is regulated during stem cell differentiation in the context of a yet-unknown epigenetic pathway that controls specific developmental genes in embryonic stem cells.
Vincenzo Calvanese, Angélica Horrillo, Abdelkrim Hmadcha, Beatriz Suárez-Álvarez, Agustín F. Fernández, Ester Lara, Sara Casado, Pablo Menéndez, Clara Bueno, Javier García‐Castro, Ruth Rubio, Pablo Lapunzina, Miguel Alaminos, Lodovica Borghese, Stefanie Terstegge, Neil J. Harrison, H. D. M. Moore, Oliver Brüstle, Carlos López‐Larrea, Peter W. Andrews, Bernat Soria, Manel Esteller, Mario F. Fraga
Pablo Aranda, Xabier Agirre, Esteban Ballestar, Enrique J. Andreu, José Román‐Gómez, Inés Prieto, José I. Martı́n-Subero, Juan C. Cigudosa, Reiner Siebert, Manel Esteller, Felipe Prósper
Jesús Espada, Esteban Ballestar, Raffaella Santoro, Mario F. Fraga, Ana Villar‐Garea, Attila Németh, L. Lopez-Serra, Santiago Ropero, Agustı́n Aranda, Helena Orozco, Vanessa Moreno, Ángeles Juarranz, J. C. Stockert, Gernot Längst, Ingrid Grummt, Wendy A. Bickmore, Manel Esteller
Discussion(0)
No comments yet. Be the first to comment.